ATG7 and neoplasm: Both autophagy inhibition by ATG3 and ATG7 knockdown and pharmacological inhibition with chloroquine energize the immunotherapy anti-PD1 and anti-CTLA4 antibodies and eventually lead to tumor regression and enhanced immune response in pancreatic cancer by regulating MHC-1 degradation through autophagy [128].